Keyphrases
Multiple Sclerosis
100%
Gene Polymorphism
100%
Mitoxantrone
100%
Pharmacodynamic Biomarker
100%
ABC Transporter Gene
100%
ABCG2
85%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
71%
Efflux
21%
Genotype
14%
Clinical Response
14%
Single nucleotide Polymorphism
14%
ATP-binding Cassette Transporter A1 (ABCA1)
14%
ABC Genes
14%
In(III)
7%
Cell Death
7%
Dose Effect
7%
Flow Cytometry
7%
Odds Ratio
7%
Risk Stratification
7%
Neuronal Cells
7%
Biopsy-proven
7%
Healthy Donors
7%
Leukocyte Subsets
7%
I to
7%
Multiple Sclerosis Treatment
7%
Monotherapy
7%
Spain
7%
Germany
7%
Disease Course
7%
Response Rate
7%
Leukocytes
7%
Myocardium
7%
Relapse Rate
7%
Cardiac Effects
7%
Variant Allele
7%
Expanded Disability Status Scale
7%
In Vitro Assay
7%
Clinical Analysis
7%
De-escalation Therapy
7%
Cardiomyopathy
7%
Glial Cells
7%
Experimental Autoimmune Encephalomyelitis
7%
Complex Allele
7%
Genotype Frequency
7%
In Vivo Data
7%
Animal Disease
7%
Cochran-Armitage Trend Test
7%
Rare Genotypes
7%
Genetic Parameters
7%
Multidrug Resistance
7%
Individualized Risk
7%
Tumefactive multiple Sclerosis
7%
Hematological Side Effects
7%
Multiple Sclerosis Functional Composite
7%
Gene Single nucleotide Polymorphism
7%
Predictor of Therapeutic Response
7%
Biochemistry, Genetics and Molecular Biology
Gene Polymorphism
100%
Transporter Genes
100%
ABC Transporter
100%
Pharmacogenetics
100%
ABCG2
100%
Genotyping
40%
Allele
30%
Single-Nucleotide Polymorphism
30%
Leukocyte
20%
ATP-binding Cassette Transporter
20%
Glucocorticoid
20%
Cell Death
10%
Autoimmunity
10%
Wild Type
10%
Multidrug Resistance
10%
Flow Cytometry
10%
Immunology and Microbiology
DNA Polymorphism
100%
Multiple Sclerosis
100%
ABC Transporter
100%
ABCG2
100%
Pharmacogenetics
100%
Allele
30%
Single Nucleotide Polymorphism
30%
In Vitro
30%
Leukocyte
20%
Glucocorticoid
20%
Wild Type
10%
Cell Death
10%
Expanded Disability Status Scale
10%
Experimental Autoimmune Encephalomyelitis
10%
Multidrug Resistance
10%
Multiple Sclerosis Functional Composite
10%
Neuroscience
DNA Polymorphism
100%
Multiple Sclerosis
100%
ABC Transporter
100%
Mitoxantrone
100%
Breast Cancer Resistance Protein
71%
In Vitro
21%
Single-Nucleotide Polymorphism
21%
In Vivo
14%
Leukocyte
14%
Glucocorticoid
14%
Side Effect
14%
Cell Death
7%
Drug Resistance
7%
Histopathology
7%
Expanded Disability Status Scale
7%
Experimental Autoimmune Encephalomyelitis
7%
Flow Cytometry
7%
Myocardial Disease
7%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Multiple Sclerosis
100%
Mitoxantrone
100%
ABC Transporter
100%
ABCG2
71%
Effusion
21%
Glucocorticoid
14%
Side Effect
14%
Monotherapy
7%
Flow Cytometry
7%
Disease Course
7%
Recurrence Risk
7%
Expanded Disability Status Scale
7%
Experimental Autoimmune Encephalomyelitis
7%
Myocardial Disease
7%
Multidrug Resistance
7%